Allen & Overy has advised Exscientia on its USD674 million AI drug discovery collaboration with Merck KGaA.Collaboration is set to harness Exscientia’s precision design capabilities to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
